Publication | Open Access

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

Proof-of-concept TrialAntifungal AgentIll Influenza PatientsInvasive Pulmonary AspergillosisRespiratory InfectionInfectious Respiratory DiseaseInfection ControlMedicineClinical MicrobiologyAntimicrobial Resistance